As Group Head of Corporate Affairs and Global Health at Novartis, Lutz Hegemann is responsible for driving forward the corporate strategy and integrating global health and environmental, social, and governance (ESG) matters into the core of the business. In this role, Lutz leads three teams: the Corporate Strategy function, which oversees the development and execution of the Novartis strategy; the ESG Management Office, which integrates ESG activities across the company; and the Global Health organization, which focuses on transforming health in low- and middle-income countries, including flagship programs targeting malaria, leprosy, sickle cell disease, and Chagas disease.
Before taking on his present role in February 2021, Lutz was Chief Operating Officer for Global Health at Novartis. He has held roles of increasing responsibility since joining the company in 2005 in the Consumer Health Division. He began his career as a public health physician and scientist and has an MD and PhD from Utrecht University in the Netherlands.
Lutz is a Fellow of the Royal Society of Tropical Medicine and Hygiene. In addition to serving on PATH’s board of directors, he also serves on the boards of the Novartis Foundation, the Swiss Alliance against Neglected Tropical Diseases, and the Tanzania Training Centre for International Health.
Appointed to the board: June 2021